Viagra® Melanoma Skin Cancer Dangers

Viagra®, or sildenafil citrate, is a popular prescription drug used to treat erectile dysfunction in male patients. The drug's manufacturer, Pfizer, claims that more than 25 million men in the United States have tried Viagra since its approval by the U.S. Food and Drug Administration (FDA) in 1998. However, studies have linked Viagra to an increased risk of developing melanoma—one of the deadliest forms of skin cancer.

If you or someone you love developed melanoma after taking Viagra, Ferrer, Poirot & Wansbrough wants to help. Powerful pharmaceutical legal teams don't intimidate our drug injury lawyers, and we’re here to protect your rights to compensation. So don't wait. Get the skilled representation you deserve today. Dial (800) 210-8503 or complete a free initial consultation form.

Viagra May Increase Melanoma Risk

A recent study of nearly 26,000 male patients suggests that men who have taken Viagra are nearly twice as likely to develop melanoma as men who have never taken the drug. Researchers determined that patients who took Viagra faced increased risks of developing melanoma regardless of their family histories of skin cancers, medical histories of other cancers, and ultraviolet exposure in regions where they lived.

Dr. Abrar Qureshi, co-author of the study and professor and chair of the Department of Dermatology at Warren Alpert Medical School of Brown University, suggests that Viagra may trigger melanoma—as opposed to other less aggressive skin cancers—because it affects the same genetic pathways that allow skin cancers to become more invasive.

Viagra® Lawsuit Help

If you or your loved one developed melanoma after taking Viagra, Ferrer, Poirot & Wansbrough can fight for you. We have more than 30 years of experience helping drug injury victims get compensation for their medical bills, lost wages, and pain and suffering, and you won't owe us anything for our legal services unless we get money for you. Contact us 24/7 to get started with your claim.

Viagra® is a registered trademark of Pfizer, Inc., and is used here only to identify the product in question. This law firm is not affiliated with, sponsored by, or associated with the Journal of the American Medical Association; Brown University; NBC News; Pfizer, Inc.; or the U.S. Food and Drug Administration.